Rhythm stockholders elect two Class II directors, approve officer exculpation amendment

RHYTHM PHARMACEUTICALS, INC.

Jennifer Good (55.6M votes for) and Edward T. Mathers (35.2M for) elected as Class II directors.
Ernst & Young ratified as independent auditor for FY2025 with 60.6M votes for, 158k against.
Non-binding advisory vote on executive compensation approved (40.9M for, 18.1M against).
Amendment to certificate of incorporation to provide officer exculpation approved (55.5M for, 3.5M against).

item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.